fbpx
Study Reveals Antioxidant Ubiquinol Supports Cognitive Health

Study Reveals Antioxidant Ubiquinol Supports Cognitive Health

Cognitive Health

In a press release, a study published in The Japanese Journal of Pharmacology reveals that daily supplementation with 100mg of Ubiquinol significantly improves cognitive function in older adults, addressing issues of memory, attention, and information processing. This randomised, double-blind, placebo-controlled trial involving 90 participants aged 50-83 demonstrates Ubiquinol’s potent antioxidant properties and its role in reducing oxidative stress and supporting mitochondrial health, offering a promising solution for the growing concern of cognitive decline in Malaysia’s ageing population.

[Press Release]

16% of Malaysians aged 60 and above are living with cognitive decline in 2024
Powerful antioxidant Ubiquinol shown to support cognitive health
Lifestyle changes and supplementation in focus as antioxidant support provide hope for cognitive health

Kuala Lumpur, 19 June 2024 – Malaysia’s ageing population is rising at a concerning rate. According to the Statistics Department, Malaysia will have an ageing population of 5.6 million, or 15% of the total population, by 2030.[1] In tandem, the number of elderly with dementia is estimated to reach 353,000 cases in 2030.[2] But there is hope. A pivotal study reveals that a daily dose of 100mg of Ubiquinol[3]  may enhance cognitive health in older adults, supporting improvement in memory, attentiveness, and work processing ability in middle-aged and elderly people.

This breakthrough research, published in The Japanese Journal of Pharmacology (2021) was conducted through a rigorous randomised, double-blind, placebo-controlled trial, underscoring the potential of Ubiquinol to support cognitive function which has been seen to be depleted due to age-related decline.

The study involved 90 adults aged between 50 and 83, monitored over a period of 34 weeks. Participants were administered a daily dose of 100mg of Kaneka Ubiquinol™, the patented bioidentical Ubiquinol ingredient made from a fermented yeast process. Cognitive performance was meticulously evaluated using established neuropsychological tests.

The findings showed that regular supplementation with Ubiquinol led to improvements in cognitive function, particularly in the domains of memory, attention, and information processing. Additionally, Ubiquinol’s potent antioxidant properties played a crucial role in reducing oxidative stress, a major factor in cognitive decline and neurodegenerative diseases. By supporting mitochondrial health, Ubiquinol enhances cellular energy production, which is vital for maintaining optimal brain health and function.

Gina Koay, Community Pharmacist said these findings continue to support the role of Ubiquinol in maintaining cognitive health, cardiovascular health and general well-being.

“As we age, the decline in cognitive function is a cause for concern as it impacts a person’s memory, recall, and processing, causing a decline in quality of life. With Malaysia transitioning to an ageing nation, there is a concern about the decline in cognitive health in older adults. It is promising that supplementation can provide an option for those looking to maintain their cognitive health and support brain function as they age.”

“This study which shows the antioxidant and mitochondrial support properties of Ubiquinol for cognition, provides an evidence-based supplementation option. It is pleasing that as healthcare professionals we can offer patients an option to help support their cognitive health and help address the growing challenge of cognitive decline in older adults.”

As the global population ages, maintaining cognitive health is becoming increasingly critical. Ubiquinol, supported by 90+ scientific studies and 80+ patents, is essential for cellular energy production and offers robust antioxidant support.

This research highlights Ubiquinol as a vital ingredient for supporting brain health and providing defensive support for age-related cognitive decline.

RESEARCH HIGHLIGHTS:

Participants: 90 adults aged 50-83, monitored over 34 weeks.

Methods: In the randomised, double-blind, placebo-controlled trial, participants were administered 100mg of Kaneka Ubiquinol™ daily. Cognitive performance was assessed using standard neuropsychological tests.

Results: Significant improvements in cognitive function were observed. Measuring cognitive domains of processing speed, sequencing, mental flexibility and visual motor skills, Ubiquinol intake improved memory, attentiveness and work processing ability.

KEY FINDINGS:

  • Enhanced cognitive function: The study reveals that regular supplementation with Kaneka Ubiquinol™ can improve cognitive function in adults, particularly in areas related to memory, attention and information processing.
  • Reduced oxidative stress: Ubiquinol’s powerful antioxidant properties help reduce oxidative stress, a major factor in cognitive decline and neurodegenerative diseases.
  • Mitochondrial support: By supporting mitochondrial health, Ubiquinol enhances cellular energy production, crucial for maintaining brain health and function.

Always read the label and follow the directions for use. Consult your healthcare professional to determine if Ubiquinol is suitable for your needs.

ABOUT KANEKA UBIQUINOL™

Japan’s Kaneka Corporation is the global supplier of world-class scientifically formulated Ubiquinol, supported by 90+ scientific studies, 80+ patents and 45+ years of research for mitochondrial health, cardiovascular health, fertility and energy production. Now listed in over 50 countries in 500 Practitioner and OTC nutraceuticals brands. Kaneka Ubiquinol™ is the recipient of the Annual Ingredient Cardiovascular Health Award 2024 by Functional Foods for Wellness Summit (FFWS) and is Champion Ingredient for Alibaba 2023-2024. 

www.ubiquinol.net.au 

Media Contacts:

Patsy Thomas            [email protected]

Isabel Andrew            [email protected]


[1] BMC Geriatrics: Development of Malaysian-MIND diet scores for prediction of mild cognitive impairment among older adults in Malaysia

[1] Spatial analysis: Ageing population of multi-ethnic in rural area, Malaysia

[1] Malaysia Population Research Hub

[1] Kinoshita T, et al. The effects of ubiquinol (reduced form of coenzyme Q10) on memory, attentiveness, and work processing ability in healthy middle-aged and elderly residents – a randomized, double-blind, placebo-controlled trial. Jpn Pharmacol Ther 2021;49:1739-1747.

 

 

 

Protect against cancer, cardiovascular disease, and other chronic diseases with regular health screening. Compare and shop for health screenings from Singapore and regional healthcare providers at a single convenient platform - shop.health365.sg

This article is informative only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment, and should never be relied upon for specific medical advice.